0001209191-18-010068.txt : 20180214 0001209191-18-010068.hdr.sgml : 20180214 20180214175341 ACCESSION NUMBER: 0001209191-18-010068 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180212 FILED AS OF DATE: 20180214 DATE AS OF CHANGE: 20180214 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ALTSHULER DAVID CENTRAL INDEX KEY: 0001550395 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 18614396 MAIL ADDRESS: STREET 1: C/O VERTEX PHARMACEUTICALS INCORPORATED STREET 2: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173416393 MAIL ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-02-12 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001550395 ALTSHULER DAVID C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE BOSTON MA 02210 0 1 0 0 EVP, Global Research and CSO Common Stock 2018-02-12 4 S 0 1750 149.23 D 74652 D Common Stock 2018-02-12 4 S 0 1900 150.67 D 72752 D Common Stock 2018-02-12 4 S 0 1953 151.40 D 70799 D Common Stock 2018-02-12 4 S 0 700 153.11 D 70099 D Common Stock 2018-02-12 4 S 0 100 153.84 D 69999 D Transaction made pursuant to Mr. Altshuler's company-approved trading plan under Rule 10b5-1. Open market sales reported on this line occurred at a weighted average price of $149.23 (range $148.77 to $149.74). Mr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Open market sales reported on this line occurred at a weighted average price of $150.67 (range $150.01 to $150.97). Open market sales reported on this line occurred at a weighted average price of $151.40 (range $151.02 to $151.90). Open market sales reported on this line occurred at a weighted average price of $153.11 (range $152.71 to $153.59). /s/ Omar White, Attorney-in-Fact 2018-02-14